UK Oil & Gas PLC
("UKOG" or the "Company")
Loan Reduction Update
UK Oil & Gas PLC (London AIM: UKOG) announces that, in relation to the funding facility announced on 28 June 2023 ("Loan"), it has issued RiverFort Global Opportunities PCC Limited and YA II PN Ltd ("Investors") a further 228,215,768 Equity Shares to repay a further £55,000 of the Loan, the principal balance of which now stands today at £0.37 million of the £2 million gross first cash sum received.
The Investors' share transactions remain subject to the orderly market, no short position and Investors voting in favour of the Company obligations as previously announced on 28 June 2023.
Admission
Application has been made for this tranche of Equity Shares, numbering 228,215,768 ordinary shares in total, to be admitted to trading on AIM ("Admission"). Admission is expected to take place at 8.00 a.m. on or around 22 May 2024.
Following Admission, the total voting rights in the Company will be 4,104,058,306 ordinary shares and Shareholders may use this figure as the denominator by which they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure, Guidance and Transparency Rules.
For further information, please contact:
UK Oil & Gas plc
Stephen Sanderson / Allen D Howard / Guzyal Mukhametzhanova Tel: 01483 941493
WH Ireland Ltd (Nominated Adviser and Broker)
James Joyce / Andrew de Andrade / James Bavister Tel: 020 7220 1666
Communications
Brian Alexander Tel: 01483 941493
The information contained within this announcement is deemed by the Company to constitute inside information under the Market Abuse Regulation (EU) No. 596/2014, as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018. Upon publication of this announcement, this information is now considered to be in the public domain.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.